Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding 1 1Edited by J. Doudna

This publication has 76 references indexed in Scilit:

• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.
  The Journal of Infectious Diseases, 1997
• Evaluation of Retinal Toxicity and Efficacy of Anti‐Cytomegalovirus and Anti‐Herpes Simplex Virus Antiviral Phosphorothioate Oligonucleotides ISIS 2922 and ISIS 4015
  The Journal of Infectious Diseases, 1997
• Trends in Infectious Diseases and Cancers among Persons Dying of HIV Infection in the United States from 1987 to 1992
  Annals of Internal Medicine, 1995
• Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs
  Antiviral Research, 1995
• Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine
  The Journal of Infectious Diseases, 1992
• The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
  New England Journal of Medicine, 1992
• A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS
  Annals of Internal Medicine, 1991
• Foscarnet Therapy for Ganciclovir-Resistant Cytomegalovirus Retinitis in Patients with AIDS
  The Journal of Infectious Diseases, 1991
• Cytomegalovirus Retinitis and Response to Therapy with Ganciclovir
  Published by Elsevier ,1987